EUVIMEDEUVIMED entdecken
Leserbrief

Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax

Stefano Cordella, Davide Giusti, Eleonora De Bellis, Michelina Dargenio, Federica Creti', Davide Lazzarotto iD, Chiara Cattaneo iD, Nicola Stefano Fracchiolla iD, Matteo Piccini, Fabio Forghieri iD, Livio Pagano, Anna Candoni

Hematological Oncology · 2024

DOI: 10.1002/hon.3310 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Hematological Oncology, 2024. Verfasst von Stefano Cordella und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emil…. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Myeloid, Acute, Sulfonamides. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bridged Bicyclo Compounds, HeterocyclicLeukemia, Myeloid, AcuteSulfonamidesHumansMaleFemaleMiddle AgedAgedAdultInfectionsAntineoplastic Combined Chemotherapy ProtocolsPrognosisNeoplasms, Second PrimarySurvival RateAged, 80 and over

Substanzen

Bridged Bicyclo Compounds, HeterocyclicvenetoclaxSulfonamides

Autor:innen und Institutionen

  • Section of Hematology, Department of Medical and Surgical Sciences, Azienda Ospedaliero-Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Division of Hematology, ASUGI, Trieste, Italy.
  • Division of Hematology, Ospedale Vito Fazzi, Lecce, Italy.
  • Division of Hematology and Stem Cell Transplantation, ASUFC, University of Udine, Udine, Italy.
  • Section of Hematology, Spedali Civili, Brescia, Italy.
  • U.O. Oncoematologia, Fondazione IRCCS Ca' Granda OspedaleMaggiore Policlinico, University of Milan, Milan, Italy.

ORCID-Profile: Davide Lazzarotto, Chiara Cattaneo, Nicola Stefano Fracchiolla, Fabio Forghieri

Zitieren

APA

Cordella, S., Giusti, D., De Bellis, E., Dargenio, M., Creti', F., Lazzarotto, D., Cattaneo, C., Fracchiolla, N. S., Piccini, M., Forghieri, F., Pagano, L., & Candoni, A. (2024). Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax. Hematological Oncology. https://doi.org/10.1002/hon.3310

Vancouver

Cordella S, Giusti D, De Bellis E, Dargenio M, Creti' F, Lazzarotto D, et al. Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax. Hematological Oncology. 2024. doi:10.1002/hon.3310

BibTeX
@article{Cordella2024,
  author = {Cordella, Stefano and Giusti, Davide and De Bellis, Eleonora and Dargenio, Michelina and Creti', Federica and Lazzarotto, Davide and Cattaneo, Chiara and Fracchiolla, Nicola Stefano and Piccini, Matteo and Forghieri, Fabio and Pagano, Livio and Candoni, Anna},
  title = {Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax},
  journal = {Hematological Oncology},
  year = {2024},
  doi = {10.1002/hon.3310}
}
Kostenlos starten →